$IDXX News

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Idexx (IDXX) Moves to Buy: Rationale Behind the Upgrade

JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

IDEXX Laboratories’ Q3 2026 Earnings: What to Expect

Keybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating

IDEXX Laboratories to Release 2026 Third Quarter Financial Results

Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference

IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics

IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide

IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus

Is IDEXX’s Expanded Zoonosis Testing Menu Altering The Investment Case For IDEXX Laboratories (IDXX)?

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock

Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories

Is IDEXX Laboratories Stock Underperforming the Dow?

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?